Kidney disease — all decisions

The Veteran's disabilities, including diabetes mellitus II with diabetic retinopathy and chronic kidney disease, rendered him unemployable as of April 19, 2019.

The Board granted a 10 percent evaluation for multiple noncompensable service-connected disabilities that interfere with normal employability, and remanded the matter of a compensable rating for colon cancer, status post resection.

The Board denied the claim for Dependency and Indemnity Compensation (DIC) based on service connection for the cause of the Veteran's death, as there was no evidence to support a finding that any of the Veteran's service-connected disabilities were related to his death.

The Board granted an earlier effective date of August 10, 2022, for the award of service connection for kidney cancer.

The Board granted service connection for the cause of the Veteran's death, finding that his renal cell carcinoma of the left kidney was related to his in-service exposure to Agent Orange.

The Board remands the matter for an addendum opinion regarding the etiology of the Veteran's chronic kidney disease, specifically to determine if it is caused or aggravated by service-connected diabetes mellitus, coronary artery disease, and hypertension.

The Board denied the Veteran's claims for service connection for heart conditions with pacemaker, hypertension, and chronic kidney disease as there was no evidence to support a causal relationship between these conditions and his active duty or service-connected pulmonary tuberculosis.

The Board remands the claim for service connection for a kidney disorder to correct a pre-decisional duty to assist error, as there is evidence of a current diagnosis that was not considered in the initial decision.

The Veteran's tinnitus and hypertension were granted service connection, while the claims for a kidney condition, heart condition, and bilateral eye condition were remanded.

The Board denied an initial compensable rating for COPD and remanded the claims for service connection for a heart disorder and chronic kidney disease.

The Board remands the claims for service connection due to a pre-decisional duty to assist error, specifically regarding the failure to obtain relevant Social Security Administration records.

The Board remands the claims for service connection for chronic kidney disease and erectile dysfunction to obtain additional medical opinions regarding their etiology, including whether they are related to toxic exposure risk activity during service or secondary to hypertension.

The Board denied service connection for a kidney condition, ED, and OSA due to the lack of evidence showing current diagnoses or etiological links to service or service-connected conditions.

The Board granted service connection for various conditions, including neoplasm of the kidney and lung cancer, effective October 2, 2020, based on herbicide exposure during service in Thailand.

The Board granted service connection for Wegener's granulomatosis, a recurrent kidney disability, and a recurrent bladder disability. The claim for an earlier effective date was denied, as well as the claims for service connection for bilateral pes planus and plantar fasciitis.

The Board remands the claim for service connection of kidney cancer due to exposure to ionizing radiation during cleanup efforts on Eniwetok Atoll, as required by the PACT Act.

The Board remands the claim for service connection for the cause of the Veteran's death to consider additional evidence regarding exposure to contaminated water at Camp Lejeune.

The appeal for service connection and increased ratings for kidney disease, hypertension, headaches, PTSD, and degenerative arthritis of the thoracolumbar spine was dismissed due to a withdrawal by the Veteran.

The Board denied the Veteran's claim for a total disability rating based on unemployability due to his service-connected disabilities, as he is shown to be employed fulltime as a police officer earning over $67,000 per year.

The Board remands the claim for a direct service connection opinion on kidney cancer, status post mass removal due to inadequate medical evidence.